Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Chavant Capital Acquisition Corp. | Director | Class A Common Stock | 1.39M | $13.9M | $10.00 | Dec 21, 2023 | Indirect |
SES AI Corp | Director | Class A Common Stock | 223K | $307K | $1.38 | Feb 6, 2024 | Direct |
Chavant Capital Acquisition Corp. | Director | Private Placement Warrants | 1.24M | Dec 21, 2023 | Indirect | ||
Chavant Capital Acquisition Corp. | Director | Make-Whole Shares (right to acquire) | 200K | Dec 21, 2023 | Indirect | ||
ANAVEX LIFE SCIENCES CORP. | Director | Stock Option (Right to Buy) | 50K | Feb 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVXL | ANAVEX LIFE SCIENCES CORP. | Feb 20, 2024 | 1 | $0 | 4 | Feb 23, 2024 | Director |
SES | SES AI Corp | Feb 6, 2024 | 1 | $0 | 4 | Feb 8, 2024 | Director |
SES | SES AI Corp | Apr 14, 2023 | 1 | $0 | 4 | Apr 18, 2023 | Director |
AVXL | ANAVEX LIFE SCIENCES CORP. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
MOBX | Chavant Capital Acquisition Corp. | Oct 10, 2022 | 6 | $2M | 4 | Dec 26, 2023 | Director |
AVXL | ANAVEX LIFE SCIENCES CORP. | Jun 27, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
SES | SES AI Corp | Apr 18, 2022 | 1 | $0 | 4 | Apr 20, 2022 | Director |
CLAY | Chavant Capital Acquisition Corp. | Feb 24, 2022 | 1 | $0 | 4 | Feb 28, 2022 | CEO and President, Director |
SES | SES AI Corp | Feb 3, 2022 | 0 | $0 | 3 | Feb 11, 2022 | Director |
CLAY | Chavant Capital Acquisition Corp. | Sep 20, 2021 | 1 | $0 | 4 | Sep 21, 2021 | CEO and President, Director |
AVXL | ANAVEX LIFE SCIENCES CORP. | Aug 2, 2021 | 1 | $0 | 4 | Aug 4, 2021 | Director |
CLAY | Chavant Capital Acquisition Corp. | Jul 19, 2021 | 0 | $0 | 3 | Jul 20, 2021 | CEO and President, Director |
AVXL | ANAVEX LIFE SCIENCES CORP. | May 25, 2021 | 0 | $0 | 3 | Jun 9, 2021 | Director |